# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-24-256654
Filing Date
2024-11-13
Accepted
2024-11-13 08:05:33
Documents
46
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d912869d8k.htm iXBRL | 8-K | 33239
2 | EX-99.1 | d912869dex991.htm | EX-99.1 | 97857
3 | EX-99.2 | d912869dex992.htm | EX-99.2 | 40363
7 | GRAPHIC | g912869ex99_2s10g1.jpg | GRAPHIC | 101029
8 | GRAPHIC | g912869ex99_2s11g1.jpg | GRAPHIC | 115800
9 | GRAPHIC | g912869ex99_2s12g1.jpg | GRAPHIC | 114647
10 | GRAPHIC | g912869ex99_2s13g1.jpg | GRAPHIC | 85680
11 | GRAPHIC | g912869ex99_2s14g1.jpg | GRAPHIC | 116577
12 | GRAPHIC | g912869ex99_2s15g1.jpg | GRAPHIC | 124172
13 | GRAPHIC | g912869ex99_2s16g1.jpg | GRAPHIC | 87528
14 | GRAPHIC | g912869ex99_2s17g1.jpg | GRAPHIC | 81779
15 | GRAPHIC | g912869ex99_2s18g1.jpg | GRAPHIC | 89571
16 | GRAPHIC | g912869ex99_2s19g1.jpg | GRAPHIC | 108028
17 | GRAPHIC | g912869ex99_2s1g1.jpg | GRAPHIC | 51441
18 | GRAPHIC | g912869ex99_2s20g1.jpg | GRAPHIC | 106075
19 | GRAPHIC | g912869ex99_2s21g1.jpg | GRAPHIC | 129444
20 | GRAPHIC | g912869ex99_2s22g1.jpg | GRAPHIC | 79639
21 | GRAPHIC | g912869ex99_2s23g1.jpg | GRAPHIC | 124063
22 | GRAPHIC | g912869ex99_2s24g1.jpg | GRAPHIC | 98290
23 | GRAPHIC | g912869ex99_2s25g1.jpg | GRAPHIC | 104749
24 | GRAPHIC | g912869ex99_2s26g1.jpg | GRAPHIC | 80997
25 | GRAPHIC | g912869ex99_2s27g1.jpg | GRAPHIC | 103954
26 | GRAPHIC | g912869ex99_2s28g1.jpg | GRAPHIC | 95766
27 | GRAPHIC | g912869ex99_2s29g1.jpg | GRAPHIC | 93457
28 | GRAPHIC | g912869ex99_2s2g1.jpg | GRAPHIC | 171880
29 | GRAPHIC | g912869ex99_2s30g1.jpg | GRAPHIC | 136136
30 | GRAPHIC | g912869ex99_2s3g1.jpg | GRAPHIC | 144053
31 | GRAPHIC | g912869ex99_2s4g1.jpg | GRAPHIC | 92612
32 | GRAPHIC | g912869ex99_2s5g1.jpg | GRAPHIC | 122713
33 | GRAPHIC | g912869ex99_2s6g1.jpg | GRAPHIC | 104850
34 | GRAPHIC | g912869ex99_2s7g1.jpg | GRAPHIC | 101193
35 | GRAPHIC | g912869ex99_2s8g1.jpg | GRAPHIC | 83284
36 | GRAPHIC | g912869ex99_2s9g1.jpg | GRAPHIC | 78833
37 | GRAPHIC | g912869g1113053650381.jpg | GRAPHIC | 2666
| Complete submission text file | 0001193125-24-256654.txt |  | 4638006

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | mcrb-20241107.xsd | EX-101.SCH | 2870
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | mcrb-20241107_lab.xml | EX-101.LAB | 17237
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | mcrb-20241107_pre.xml | EX-101.PRE | 10826
48 | EXTRACTED XBRL INSTANCE DOCUMENT | d912869d8k_htm.xml | XML | 3507

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37465 | Film No.: 241451275
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)